ID

28302

Descripción

Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00984048

Link

https://clinicaltrials.gov/show/NCT00984048

Palabras clave

Versiones (1)
  1. 3/1/18 3/1/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

3 de enero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Colorectal Cancer NCT00984048

Inglés

Eligibility Colorectal Cancer NCT00984048

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with a histologically confirmed diagnosis of colorectal cancer, with at least one liver metastasis site available for biopsy.
Descripción

Colorectal Carcinoma | Secondary malignant neoplasm of liver | Site Quantity Availability Biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009402
UMLS CUI [2]
C0494165
UMLS CUI [3,1]
C1515974
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C0470187
UMLS CUI [3,4]
C0005558
2. for patients with liver only disease, patients deemed not to be initially resectable
Descripción

Liver disease unresectable Initially

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023895
UMLS CUI [1,2]
C1519810
UMLS CUI [1,3]
C0205265
3. scheduled to receive first-line chemotherapy (folfox/bevacizumab or folfiri/bevacizumab) for metastatic disease.
Descripción

First line Chemotherapy Scheduled Neoplasm Metastasis | FOLFOX Regimen | bevacizumab | FOLFIRI Regimen

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C0392920
UMLS CUI [1,3]
C0205539
UMLS CUI [1,4]
C0027627
UMLS CUI [2]
C0392943
UMLS CUI [3]
C0796392
UMLS CUI [4]
C1880658
4. measurable metastatic disease (at least one unidimensionally measurable lesion) present after planned biopsy of metastatic site(s).
Descripción

Neoplasm Metastasis Measurable | Measurable lesion Linear Quantity | Metastatic cancer site Biopsy Planned

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C1513040
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0205132
UMLS CUI [2,3]
C1265611
UMLS CUI [3,1]
C0280457
UMLS CUI [3,2]
C0005558
UMLS CUI [3,3]
C1301732
5. ecog 0, 1 or 2.
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
6. life expectancy of 12 or more weeks.
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
7. age > 18 years.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
8. able to adhere to the study visit schedule and other protocol requirements.
Descripción

Protocol Compliance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0525058
9. normal coagulation profile (pt, ptt, inr).
Descripción

Coagulation profile Normal | Prothrombin time | PTT | INR

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0005790
UMLS CUI [1,2]
C0205307
UMLS CUI [2]
C0033707
UMLS CUI [3]
C0030605
UMLS CUI [4]
C0525032
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. patients with initially resectable liver only metastases
Descripción

Secondary malignant neoplasm of liver Resectable Initially

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0494165
UMLS CUI [1,2]
C1514888
UMLS CUI [1,3]
C0205265
2. have received prior therapy for metastatic cancer. prior adjuvant therapy is allowed.
Descripción

Prior Therapy Neoplasm Metastasis | Adjuvant therapy allowed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0027627
UMLS CUI [2,1]
C0677850
UMLS CUI [2,2]
C0683607
3. inadequate or unusable tissue as the only tissue available for biopsy.
Descripción

Tissue specimen Inadequate Biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1292533
UMLS CUI [1,2]
C0205412
UMLS CUI [1,3]
C0005558
4. contraindication to any of the components of the the first-line chemotherapy regimen.
Descripción

Medical contraindication First line Chemotherapy Regimen Component

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C1708063
UMLS CUI [1,3]
C0392920
UMLS CUI [1,4]
C1705248
5. known brain metastases or meningeal disease.
Descripción

Metastatic malignant neoplasm to brain | Meningeal disorder

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0154728
6. female patients who are pregnant or breastfeeding.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
7. concurrent treatment with other anti-cancer therapy (palliative radiation is allowed but patients must have a metastatic site available for re-biopsy that has not been irradiated).
Descripción

Cancer treatment Other | Palliative Radiation Therapy allowed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0920425
UMLS CUI [1,2]
C0205394
UMLS CUI [2,1]
C3898008
UMLS CUI [2,2]
C0683607
8. abnormal coagulation profile, any anti-coagulant therapy.
Descripción

Abnormal coagulation profile | Anticoagulant therapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0375576
UMLS CUI [2]
C0150457
9. known infection with hiv.
Descripción

HIV Infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019693
Volver a la parte superior de la página

Similar models

Eligibility Colorectal Cancer NCT00984048

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Colorectal Carcinoma | Secondary malignant neoplasm of liver | Site Quantity Availability Biopsy
Item
1. patients with a histologically confirmed diagnosis of colorectal cancer, with at least one liver metastasis site available for biopsy.
boolean
C0009402 (UMLS CUI [1])
C0494165 (UMLS CUI [2])
C1515974 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0470187 (UMLS CUI [3,3])
C0005558 (UMLS CUI [3,4])
Liver disease unresectable Initially
Item
2. for patients with liver only disease, patients deemed not to be initially resectable
boolean
C0023895 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C0205265 (UMLS CUI [1,3])
First line Chemotherapy Scheduled Neoplasm Metastasis | FOLFOX Regimen | bevacizumab | FOLFIRI Regimen
Item
3. scheduled to receive first-line chemotherapy (folfox/bevacizumab or folfiri/bevacizumab) for metastatic disease.
boolean
C1708063 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
C0027627 (UMLS CUI [1,4])
C0392943 (UMLS CUI [2])
C0796392 (UMLS CUI [3])
C1880658 (UMLS CUI [4])
Neoplasm Metastasis Measurable | Measurable lesion Linear Quantity | Metastatic cancer site Biopsy Planned
Item
4. measurable metastatic disease (at least one unidimensionally measurable lesion) present after planned biopsy of metastatic site(s).
boolean
C0027627 (UMLS CUI [1,1])
C1513040 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0205132 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0280457 (UMLS CUI [3,1])
C0005558 (UMLS CUI [3,2])
C1301732 (UMLS CUI [3,3])
ECOG performance status
Item
5. ecog 0, 1 or 2.
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
6. life expectancy of 12 or more weeks.
boolean
C0023671 (UMLS CUI [1])
Age
Item
7. age > 18 years.
boolean
C0001779 (UMLS CUI [1])
Protocol Compliance
Item
8. able to adhere to the study visit schedule and other protocol requirements.
boolean
C0525058 (UMLS CUI [1])
Coagulation profile Normal | Prothrombin time | PTT | INR
Item
9. normal coagulation profile (pt, ptt, inr).
boolean
C0005790 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
C0033707 (UMLS CUI [2])
C0030605 (UMLS CUI [3])
C0525032 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Secondary malignant neoplasm of liver Resectable Initially
Item
1. patients with initially resectable liver only metastases
boolean
C0494165 (UMLS CUI [1,1])
C1514888 (UMLS CUI [1,2])
C0205265 (UMLS CUI [1,3])
Prior Therapy Neoplasm Metastasis | Adjuvant therapy allowed
Item
2. have received prior therapy for metastatic cancer. prior adjuvant therapy is allowed.
boolean
C1514463 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0677850 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
Tissue specimen Inadequate Biopsy
Item
3. inadequate or unusable tissue as the only tissue available for biopsy.
boolean
C1292533 (UMLS CUI [1,1])
C0205412 (UMLS CUI [1,2])
C0005558 (UMLS CUI [1,3])
Medical contraindication First line Chemotherapy Regimen Component
Item
4. contraindication to any of the components of the the first-line chemotherapy regimen.
boolean
C1301624 (UMLS CUI [1,1])
C1708063 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C1705248 (UMLS CUI [1,4])
Metastatic malignant neoplasm to brain | Meningeal disorder
Item
5. known brain metastases or meningeal disease.
boolean
C0220650 (UMLS CUI [1])
C0154728 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
6. female patients who are pregnant or breastfeeding.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Cancer treatment Other | Palliative Radiation Therapy allowed
Item
7. concurrent treatment with other anti-cancer therapy (palliative radiation is allowed but patients must have a metastatic site available for re-biopsy that has not been irradiated).
boolean
C0920425 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C3898008 (UMLS CUI [2,1])
C0683607 (UMLS CUI [2,2])
Abnormal coagulation profile | Anticoagulant therapy
Item
8. abnormal coagulation profile, any anti-coagulant therapy.
boolean
C0375576 (UMLS CUI [1])
C0150457 (UMLS CUI [2])
HIV Infection
Item
9. known infection with hiv.
boolean
C0019693 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial